Etodolac improves 5-FU sensitivity of head and neck cancer cells through inhibition of thymidylate synthase.
Shogo Murata(Yokohama City University), Iwai Tohnai(Saitama Medical University), Mihir K. Bhayani(Rush University Medical Center), Tetsuya Ogawa(Nihon University), Soichiro Torigoe, Kenji Mitsudo(Yokohama City University), Kei Ijichi(Nagoya City University), Stephen Y. Lai(The University of Texas MD Anderson Cancer Center), Mitomu Kioi(Yokohama City University), Yasuhisa Hasegawa(Asahi University), Makoto Adachi(Aichi Cancer Center)
PubMed
September 1, 2011
Cited by 14
Related Papers
Dynamic Imaging Grade of Swallowing Toxicity (DIGEST): Scale development and validation
|Cancer|2016|254
Complete Surgical Resection Following Neoadjuvant Dabrafenib Plus Trametinib in <i> BRAF <sup>V600E</sup> </i> -Mutated Anaplastic Thyroid Carcinoma
|Thyroid|2019|229
Sebaceous carcinoma: evidence-based clinical practice guidelines
|The Lancet Oncology|2019|204
Left Ventricular Hypertrophy Is Associated with Arterial Stiffness and Vascular Calcification in Hemodialysis Patients
|Hypertension Research|2004|161